Search Browse Earnings

DBV Technologies S.A. — SlamSEC

DBV Technologies S.A.

Nasdaq:DBVTOTC:DBVTF

Biological Products, (No Diagnostic Substances)·CHATILLON, I0

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$15.7M

+224.7% YoY

FY 2024

Adj. EBITDA

-$72.9M

-463.3% margin

FY 2024

Net Income

-$72.7M

-462.4% margin

FY 2024

EPS (Diluted)

-$0.76

FY 2024

Stock Price

$22.90

+4.7%

2026-03-09

52W Range

$3.91 – $26.18

P/E Ratio

-30.1x

Market Cap

$3.9B

Cash

$141.4M

FY 2024

Total Debt

$648,000

FY 2020

Net Cash

$140.7M

FY 2020

Enterprise Value

$3.7B

Debt / EBITDA

1.9x

FY 2024

EV / EBITDA

-51.2x

Employees

104

FY 2024